HomeFHTX • NASDAQ
add
Foghorn Therapeutics Inc
Previous close
$4.90
Day range
$4.76 - $5.02
Year range
$2.94 - $10.25
Market cap
270.90M USD
Avg Volume
114.64K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 5.95M | 17.86% |
Operating expense | 7.24M | -6.11% |
Net income | -18.83M | 24.71% |
Net profit margin | -316.43 | 36.12% |
Earnings per share | -0.30 | 49.15% |
EBITDA | -22.09M | 19.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 220.59M | 6.74% |
Total assets | 258.69M | 1.45% |
Total liabilities | 320.34M | -9.12% |
Total equity | -61.65M | — |
Shares outstanding | 55.74M | — |
Price to book | -4.41 | — |
Return on assets | -21.11% | — |
Return on capital | 325.50% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -18.83M | 24.71% |
Cash from operations | -23.97M | 18.32% |
Cash from investing | 29.40M | 8.51% |
Cash from financing | 139.00K | -88.09% |
Net change in cash | 5.57M | 614.50% |
Free cash flow | -5.53M | 70.76% |
About
Founded
2015
Website
Employees
112
